AtriCure, Inc.
AtriCure is a global leader in developing and delivering innovative medical devices and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. With a mission to improve patient outcomes through clinical research, innovation, and education, AtriCure has expanded its treatment options over 25 years, helping treat over 1 million patients worldwide. The company is committed to advancing surgical treatments and therapies, supporting healthcare professionals, and improving quality of life for patients.
Industries
Nr. of Employees
large (251-1000)
Patents
Products
Left atrial appendage exclusion clip systems
Surgical clip systems intended to mechanically exclude the left atrial appendage during cardiac procedures, available in configurations for minimally invasive approaches.
Cryo nerve block probes
Cryotherapy probes designed to provide reversible targeted nerve block for perioperative and post-operative pain management.
Surgical ablation instrument and generator systems
A suite of instruments (clamps, linear pens) and ablation energy generator platforms used to create therapeutic lesions in cardiac tissue for arrhythmia treatment.
Epicardial access systems
Instrumentation intended to enable safe pericardial/epicardial access for device placement and epicardial ablation procedures.
Minimally invasive surgical instrument sets
Handheld instruments and accessories such as lift systems, graspers, retractors, needle holders and scissors designed to support minimally invasive cardiac procedures.
Interactive 3D heart education application
Mobile application providing an interactive three-dimensional heart model for education and procedural planning, including annotation and lesion-set drawing capabilities.
Left atrial appendage exclusion clip systems
Surgical clip systems intended to mechanically exclude the left atrial appendage during cardiac procedures, available in configurations for minimally invasive approaches.
Cryo nerve block probes
Cryotherapy probes designed to provide reversible targeted nerve block for perioperative and post-operative pain management.
Surgical ablation instrument and generator systems
A suite of instruments (clamps, linear pens) and ablation energy generator platforms used to create therapeutic lesions in cardiac tissue for arrhythmia treatment.
Epicardial access systems
Instrumentation intended to enable safe pericardial/epicardial access for device placement and epicardial ablation procedures.
Minimally invasive surgical instrument sets
Handheld instruments and accessories such as lift systems, graspers, retractors, needle holders and scissors designed to support minimally invasive cardiac procedures.
Interactive 3D heart education application
Mobile application providing an interactive three-dimensional heart model for education and procedural planning, including annotation and lesion-set drawing capabilities.
Services
Structured clinician education including foundational programs, multidisciplinary summits, advanced practice provider workshops, didactic sessions and hands-on/cadaver labs.
Provision of online accredited modules and contact hours via partner platforms to support clinician continuing education.
Sponsorship, study design support, site collaboration and registry management for clinical investigations evaluating safety and effectiveness of surgical and perioperative therapies.
Health economic model development, administrative claims analysis, coding and reimbursement guides, hospital value-analysis toolkits and payer engagement to support market access.
Centralized web portal providing technical documentation, procedural guides, videos, animations and interactive applications to support procedural planning and clinician education.
Web-based directory to locate qualified treatment teams and facilitate referrals for specialized therapies.
Structured clinician education including foundational programs, multidisciplinary summits, advanced practice provider workshops, didactic sessions and hands-on/cadaver labs.
Provision of online accredited modules and contact hours via partner platforms to support clinician continuing education.
Sponsorship, study design support, site collaboration and registry management for clinical investigations evaluating safety and effectiveness of surgical and perioperative therapies.
Health economic model development, administrative claims analysis, coding and reimbursement guides, hospital value-analysis toolkits and payer engagement to support market access.
Centralized web portal providing technical documentation, procedural guides, videos, animations and interactive applications to support procedural planning and clinician education.
Web-based directory to locate qualified treatment teams and facilitate referrals for specialized therapies.
Expertise Areas
- Clinical trial management and multicenter registries
- Post-market surveillance and real-world evidence generation
- Pivotal/IDE and randomized device trial conduct
- Clinical education and accredited CME programs
Key Technologies
- Epicardial radiofrequency ablation systems
- Bipolar surgical radiofrequency ablation devices
- Cryoablation probes for nerve block
- Left atrial appendage exclusion/clipping systems
News & Updates
AtriCure Rings the Opening Bell
Celebrating its 25th anniversary with a visit to Nasdaq MarketSite in Times Square.
LeAAPS Trial Completes Enrollment
The clinical trial for Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction has completed enrollment.
The Next Generation AtriClip Device
Introduction of the AtriClip PRO-Mini device, designed for minimally invasive procedures.
20 Years on Nasdaq and 25 Years Since Founding
Celebrating two milestones in the company's history.
Q2 Financial Results and Outlook
Reporting strong financial performance and raising outlook for 2025.
Top Workplaces 2025
Recognition as a top workplace for 2025.
AtriCure Rings the Opening Bell
Celebrating its 25th anniversary with a visit to Nasdaq MarketSite in Times Square.
LeAAPS Trial Completes Enrollment
The clinical trial for Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction has completed enrollment.
The Next Generation AtriClip Device
Introduction of the AtriClip PRO-Mini device, designed for minimally invasive procedures.
20 Years on Nasdaq and 25 Years Since Founding
Celebrating two milestones in the company's history.
Q2 Financial Results and Outlook
Reporting strong financial performance and raising outlook for 2025.
Top Workplaces 2025
Recognition as a top workplace for 2025.